Analogic Plans to Accelerate Expansion Into Point-of-Care Market Upon Completion of Ultrasonix Acquisition
Combination of BK Medical and Ultrasonix Builds Strong Ultrasound Product Portfolio
PEABODY, Mass., Jan. 29, 2013 -- Analogic Corporation (Nasdaq:ALOG), enabling the world's medical imaging and aviation security technology, confirmed its support for the Ultrasonix product line upon completion of the acquisition of Ultrasonix Medical Corporation, a supplier of advanced ultrasound systems for point-of-care and general imaging applications. Ultrasonix has over 5,000 systems installed worldwide, and would bring key ultrasound products, technology, and sales channels that are complementary to Analogic's ultrasound business.
"Once the acquisition is complete, Ultrasonix will be a significant contributor to Analogic's Ultrasound Group," said Farley Peechatka, senior vice president and general manager, Global Ultrasound Business, Analogic. "With a solid installed base, superb portfolio of ultrasound products, unique GPS technology for needle guidance, and intuitive graphical user interface, Ultrasonix will help accelerate our presence and growth in point-of-care applications in developed countries, and general imaging in emerging markets. We will continue to improve and advance both the Ultrasonix and BK Medical product lines to ensure that existing and new customers get the best products, support, and service that we can offer."
Analogic and Ultrasonix are recognized as two of the world's leading producers of portable, procedure-driven, guided ultrasound technology. Founded in 2000, Ultrasonix has a broad portfolio of both portable and cart-based ultrasound systems with a recognized brand used primarily for point-of-care applications such as emergency medicine, anesthesia, and reproductive medicine, as well as general imaging in emerging markets. Analogic's BK Medical ultrasound solutions are used to improve the practice of medicine in procedure-driven markets—urology, surgery, and anesthesia. BK Medical's products, including its award-winning Flex Focus™ family of systems and unique transducer designs, offer advanced imaging capabilities that enable real-time image guidance in an easy-to-use, portable platform.
"We are eager to bring these comprehensive and complementary product portfolios together for an even stronger suite of advanced ultrasound systems for customers of both companies," said Lars Shaw, vice president of global marketing at Analogic. "In the point-of-care market, we believe our combined Anesthesia product portfolio will be much stronger. We anticipate that Ultrasonix will also complement our existing BK Medical urology and surgery product portfolio for both the hospital and office-based practice. We will continue to support Ultrasonix reproductive medicine customers with innovative technologies. Ultrasonix general imaging products are targeted for fast growing, emerging markets, which should allow us to better address emerging markets with a strong product portfolio."
The acquisition transaction is expected to close in late February 2013.
Any statements about future expectations, plans, and prospects for the Company, including statements containing the words " believes," " anticipates," " plans," " expects," and similar expressions, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including risks relating to product development and commercialization, limited demand for the Company's products, risks associated with competition, uncertainties associated with regulatory agency approvals, competitive pricing pressures, downturns in the economy, the risk of potential intellectual property litigation, and other factors discussed in our most recent quarterly report filed with the Securities and Exchange Commission. In addition, the forward-looking statements included in this presentation represent the Company's views as of the date of this document. While the Company anticipates that subsequent events and developments will cause the Company's views to change, the Company specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing the Company's views as of any later date.
Analogic (Nasdaq:ALOG) provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging systems and technology that enable computed tomography, ultrasound, digital mammography, and magnetic resonance imaging (MRI), as well as automated threat detection for aviation security. Our CT, MRI, digital mammography, and ultrasound transducer products are sold to original equipment manufacturers (OEMs), providing state-of-the-art capability and enabling them to enter new markets and expand their existing market presence. Our market-leading BK Medical branded ultrasound systems are sold to clinical end users through our direct sales force. For over 40 years we've enabled customers to thrive, improving the health and enhancing the safety of people around the world. Analogic is headquartered just north of Boston, Massachusetts. For more information, visit www.analogic.com.